Prophylaxis of mycobacterial infections in immunocompromised patients

American Family Physician

Volumn 54, Issue 6, 1996, Pages 1981-1988

  Krance, Mary Beth ^a   Fisher, Melanie Ann ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFABUTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG CHOICE; DRUG RESISTANCE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE STATUS; LIVER TOXICITY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; OPTIC NERVE DISEASE; PELLAGRA; PERIPHERAL NEUROPATHY; PROPHYLAXIS; REVIEW; SEIZURE; TREATMENT INDICATION; TREATMENT PLANNING;

ALGORITHMS; ANTITUBERCULAR AGENTS; HUMANS; IMMUNOCOMPROMISED HOST; ISONIAZID; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0029795314     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Barnes PF, Barrows SA. Tuberculosis in the 1990s. Ann Intern Med 1993;119:400-10.
2. Management of persons exposed to multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 1992;41(RR-11):61-71.
3. Haas DW, Des Prez RM. Mycobacterial diseases. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:2213-43.
4. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 1994;120:932-44.
5. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
6. Moreno S, Baraia-Etxaburu J, Bouza E, Parras F, Perez-Tascon M, Miralles P, et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993;119:194-8.
7. Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1995;44(RR-11):19-34.
8. Brady MT. Treatment of human immunodeficiency virus infection and its associated complications in children. J Clin Pharmacol 1994;34:17-29.
9. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Research Center. Pediatr Infect Dis J 1993;12:513-22 [Published erratum appears in Pediatr Infect Dis J 1993;12:19].
10. Van Scoy RE, Wilkowske CJ. Antituberculous agents. Mayo Clin Proc 1992;67:179-87.
11. Drug facts and comparisons. St. Louis: Facts and Comparisons, 1995.
12. American Academy of Pediatrics. Tuberculosis. In: 1994 Red book: report of the Committee on Infectious Diseases. 23d ed. Elk Grove Village, Ill.: American Academy of Pediatrics, 1994:493.
13. Johnson KB, ed. The Harriet Lane handbook: a manual for pediatric house officers. 13th ed. St. Louis: Mosby, 1993:527.
14. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. Am Rev Respir Dis 1992;145:36-41.
15. Lecoeur HF, Truffot-Pernot C, Grosset JH. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide. Am Rev Respir Dis 1989;140:1189-93.
16. Kaplan MH, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer 1974;33:850-8.
17. Pickleman JR, Evans LS, Kane JM, Freeark RJ. Tuberculosis after jejunoileal bypass for obesity. JAMA 1975;234:744.
18. Andrew OT, Schoenfeld PY, Hopewell PC, Humphreys MH. Tuberculosis in patients with endstage renal disease. Am J Med 1980;68:59-65.
19. Lloveras J, Peterson PK, Simmons RL, Najarian JS. Mycobacterial infections in renal transplant recipients. Seven cases and a review of the literature. Arch Intern Med 1982;142:888-92.
20. Hamadeh MA, Glassroth J. Tuberculosis and pregnancy. Chest 1992;101:1114-20.
21. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. MMWR Morb Mortal Wkly Rep 1993;42(RR-9):14-20.
22. Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992;165:1082-5.
23. Nightingale SD, Cameron DW, Gordin FM, Sullam PM, Cohn DL, Chaisson RE, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828-33.
24. Masur H. Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex. N Engl J Med 1993;329:898-904.
25. Brogden RN, Fitton A. Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994;47:983-1009.
26. Benson CA, Ellner JJ. Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clin Infect Dis 1993;17:7-20.
27. Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, et al. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 1996;335:384-91.
28. Havlir DV, Dube MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, et al. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. N Engl J Med 1996;335:392-8.
29. Horsburgh CR. Advances in the prevention and treatment of Mycobacterium avium disease. N Engl J Med 1996;335:428-9.
30. Pierce MA. Prophylaxis of Mycobacterium avium complex infection in patients with advanced HIV infection. AIDS Reader 1995;March/April:44-8.